SUBSCRIBE
SUBSCRIBE

DNA Script

NEWS
Drug Development
How COVID-19 is Affecting Clinical Trials and Drug Supplies from Biotech Bay Companies
Check out this article for the impacts that Biotech Bay companies are experiencing due to COVID-19.
June 4, 2020
 · 
19 min read
 · 
Chelsea Weidman Burke, M.S.
Load More
IN THE PRESS
Press Releases
DNA Script Appoints Marc Montserrat as CEO to Drive Long-Term Commercial Growth for Groundbreaking Enzymatic DNA Synthesis Platform
October 18, 2024
 · 
3 min read
Biotech Bay
DNA Script to Unveil Industry’s Most Versatile On-site, On-Demand DNA Printer at the World’s Largest Synthetic Biology Conference
May 22, 2023
 · 
4 min read
Biotech Bay
DNA Script Extends Distributorships to Middle East to Expand Access to Same-day Enzymatic DNA Synthesis
October 12, 2022
 · 
3 min read
Biotech Bay
DNA Script Wins the Grand Prize Trophy at the 2022 French Future Unicorns Ceremony
September 16, 2022
 · 
3 min read
Biotech Bay
French Defense Innovation Agency Investigates the Use of DNA Script’s SYNTAX System to Synthesize Custom qPCR Probes for On-demand Detection of Biothreats
June 28, 2022
 · 
3 min read
Business
DNA Script Appoints Chris Barbazette as Chief Commercial Officer
May 10, 2022
 · 
3 min read
Biotech Bay
DNA Script Launches Early Access Program for Latest Advancements to the SYNTAX Platform and Enzymatic DNA Synthesis Technology
April 12, 2022
 · 
3 min read
Biotech Bay
DNA Script Partners with Asia-Pacific Distributors as Part of Global Expansion to Meet Demand for Same-day Enzymatic DNA Synthesis
April 5, 2022
 · 
3 min read
Biotech Bay
DNA Script Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022
March 8, 2022
 · 
5 min read
Biotech Bay
DNA Script Joins Wellcome Leap R3 Program to Advance RNA Products and Therapies
February 2, 2022
 · 
3 min read
Load More
JOBS